A6 Pharmaceuticals
A6 Pharmaceuticals is developing small molecule ARF6 inhibitors for a variety of conditions. Because ARF6 plays a critical role in pathologic protein trafficking, inhibition of ARF6, using our proprietary compounds, has been shown to be effective in animal models of acute lung injury/acute respiratory distress, certain types of cancer, diabetic retinopathy, age-related macular degeneration, and severe cerebral malaria.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
—
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at A6 Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at A6 Pharmaceuticals
2 distinct titles indexed · top 2 shown.
- 1co-founder and executive chairman, a6 pharmaceuticals
- 1non commissioned officer
Sign up to unlock all 2 contacts at A6 Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at A6 Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.